Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland · Delayed Price · Currency is CHF 14.12
-0.70 (-4.72%)
Oct 22, 2026, 5:30 PM CEST
SWX:SANN Market Cap
SWX:SANN has a market cap or net worth of 216.06 million as of October 22, 2026. It is the 18,781st most valuable company in the world and the 164th biggest in Switzerland. Its market cap has increased by 58.15% in one year.
Market Cap
216.06M
Enterprise Value
215.57M
Revenue
101.50M
Global Rank
Country Rank
#164 Switzerland
PE Ratio
n/a
ChartMarket Cap Chart
Since November 3, 2006, SWX:SANN's market cap has decreased from 357.28M to 216.06M, a decrease of -39.53%. That is a compound annual growth rate of -2.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 216.06M | 28.26% |
| Dec 30, 2025 | 168.45M | 0.68% |
| Dec 30, 2024 | 167.31M | 85.24% |
| Dec 29, 2023 | 90.32M | 19.92% |
| Dec 30, 2022 | 75.32M | 34.92% |
| Dec 30, 2021 | 55.82M | 3.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 6.35B |
| Idorsia | 1.11B |
| Basilea Pharmaceutica AG | 827.20M |
| Newron Pharmaceuticals | 175.22M |
| BioVersys AG | 145.46M |
| Molecular Partners AG | 117.98M |
| Xlife Sciences AG | 52.48M |
| MindMaze Therapeutics Holding | 23.80M |